Delivery Order SPE2DB22D3301-SPE2DB23FZ2YK
Award Date 8/9/23
Potential Completion Date 8/30/23
Potential Value $68K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $226,187.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 mg/10 ml vials. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by October 17, 2023 under the prime contract vehicle. No set aside designation or subcontractors were indicated. This supports the Defense Logistics Agency's mission to provide medical...
- The Defense Logistics Agency awarded a $45,237 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The firm fixed price order is valued at forty-five thousand two hundred thirty-seven dollars and will be performed in Conshohocken, Pennsylvania under the agency's Pharmaceutical Prime Vendor contract vehicle from August 3rd to August 24th, 2023. Amerisourcebergen will supply the multiple sclerosis treatment to the DLA, which manages the Department of Defense's...
- The Defense Logistics Agency awarded a $12,019.28 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $48,077.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $22,618.72 to Amerisourcebergen Drug Corporation for the supply of 4561544236 Ocrevus 300 MG/10 ML Vials. Amerisourcebergen will deliver 10 ML vials of the multiple sclerosis treatment Ocrevus to a location in Conshohocken, Pennsylvania, with performance required between July 19, 2023 and August 9, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen is well positioned through...
- The Defense Logistics Agency awarded a delivery order valued at $24,038.58 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed price delivery order with an ultimate completion date of June 24, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $120,192.80 and a firm fixed price structure. The order is scheduled for completion by October 14, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $12,019.28 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 22, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $113,093.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The contract has a period of performance from August 6, 2023 through August 25, 2023, with performance taking place in Conshohocken, Pennsylvania. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and this...
- The Defense Logistics Agency Troop Support Medical awarded a $113,093.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The delivery order is for 10 ML vials of Ocrevus, a multiple sclerosis treatment, to be shipped to a facility located in Conshohocken, Pennsylvania by September 21, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor for this delivery order placed against an unspecified multiple award contract...